RecruitingNCT01094327

Proteinuria in Pre and Post Transplant

Evaluation of Recipients With and Without Proteinuria, Pre and Post Kidney Transplantation


Sponsor

University of Miami

Enrollment

100 participants

Start Date

Feb 1, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.


Eligibility

Max Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with proteinuria. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Miami Miller School of Medicine Transplant Clinic

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01094327


Related Trials